{"filings":[{"id":95205,"accession_number":"0001754195-26-000030","cik":1754195,"company_name":"Trulieve Cannabis Corp.","ticker":"TCNNF","form_type":"8-K","filed_at":"2026-05-07T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Trulieve Q1 2026: Revenue $287M, Net Income $2M, Adjusted EBITDA $100M, Gross Margin 59%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 revenue $287M; gross margin 59% ($170M gross profit); 92% of revenue from retail sales.","Positive GAAP net income $2M; adjusted net income $20M; adjusted EBITDA $100M (35% of revenue).","Cash from operations $56M, free cash flow $42M; cash at quarter end $353M.","Closed $60M private placement of senior secured notes due 2030.","Opened three new Florida dispensaries; rewards program reached 1M members; DEA registration enabled by Schedule III rescheduling."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":286754000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":2271147618.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95204,"accession_number":"0001754195-26-000023","cik":1754195,"company_name":"Trulieve Cannabis Corp.","ticker":"TCNNF","form_type":"8-K","filed_at":"2026-04-21T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Trulieve director Thad Beshears will not stand for reelection at June 9, 2026 annual meeting","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Beshears, a director since 2015, notified Trulieve on April 15, 2026 of his decision.","His departure is effective as of the annual shareholders meeting scheduled for June 9, 2026.","Beshears stated his decision was not due to any disagreement with the company on operations, policies, or practices."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":2271147618.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108088,"accession_number":"0001754195-26-000021","cik":1754195,"company_name":"Trulieve Cannabis Corp.","ticker":"TCNNF","form_type":"8-K","filed_at":"2026-03-05T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Trulieve CAO Joy Malivuk terminated without cause; Brett Walsh appointed successor","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Joy Malivuk terminated without cause; employment ends May 28, 2026 after 90-day notice period.","She receives accrued pay, earned bonus, severance per agreement, and vesting of equity awards.","Brett Walsh appointed Chief Accounting Officer effective Feb 28, 2026; previously Executive Corporate Controller.","Walsh's base salary set at $245,000; annual bonus target 20% for FY2025, then 35% from FY2026 onward.","Walsh eligible for annual equity awards and standard executive benefits; no family or conflict disclosures."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":2271147618.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108087,"accession_number":"0001754195-26-000017","cik":1754195,"company_name":"Trulieve Cannabis Corp.","ticker":"TCNNF","form_type":"8-K","filed_at":"2026-02-26T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Trulieve reports FY2025 revenue $1.2B, 60% gross margin, record operating cash flow $273M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Record FY2025 revenue $1.2B; 60% gross margin; adjusted EBITDA $427M (36% of revenue).","Record cash flow from operations $273M; free cash flow $229M; cash $256M at year-end.","Redeemed $368M of 2026 senior secured notes; closed $140M private placement of notes due 2030.","Grew to 233 dispensaries, 915K rewards members; sold 50.1M branded units (+5% YoY).","Net loss $116M; adjusted net loss $27M; conditional Texas Dispensing Organization license approved."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.58,"consensus_revenue_estimate":null,"consensus_revenue_actual":1181180000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2271147618.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108086,"accession_number":"0001754195-26-000014","cik":1754195,"company_name":"Trulieve Cannabis Corp.","ticker":"TCNNF","form_type":"8-K","filed_at":"2026-02-18T23:59:59+00:00","items":[],"status":"ready","headline":"Trulieve raises CEO salary to $900k; CPO and CTO also get increases and bonuses","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Kim Rivers salary increased from $850,000 to $900,000, effective Jan 1, 2026.","CPO Kyle Landrum salary increased from $350,000 to $375,000 plus a $25,000 bonus for 2025.","CTO Nilyum Jhala salary increased from $350,000 to $375,000 plus a $50,000 bonus for 2025.","Compensation Committee approved changes on Feb 12, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":2271147618.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108085,"accession_number":"0001754195-26-000005","cik":1754195,"company_name":"Trulieve Cannabis Corp.","ticker":"TCNNF","form_type":"8-K","filed_at":"2026-01-29T23:59:59+00:00","items":["1.01","2.03","8.01","9.01"],"status":"ready","headline":"Trulieve closes $60M tranche of 10.5% senior secured notes due 2030, total $200M","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued additional $60M principal at 10.5% due Dec 17, 2030; price $1,000 + accrued interest of $12.37 per $1,000.","Total outstanding Notes now $200M after two tranches (Dec 17, 2025 + Jan 29, 2026).","Net proceeds to be used for capital expenditures and general corporate purposes.","Notes are senior secured, guaranteed by Trulieve US, and rank senior to unsecured debt.","Offering conducted on best-efforts basis via Canaccord Genuity as sole agent."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":2271147618.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124508,"accession_number":"0001754195-25-000074","cik":1754195,"company_name":"Trulieve Cannabis Corp.","ticker":"TCNNF","form_type":"8-K","filed_at":"2025-12-17T23:59:59+00:00","items":["1.01","2.03","8.01","9.01"],"status":"ready","headline":"Trulieve closes $140M private placement of 10.5% senior secured notes due 2030","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$140M aggregate principal of 10.5% senior secured notes due Dec 17, 2030 closed; size increased due to demand.","Notes issued at 100% of face value, interest payable semi-annually starting June 17, 2026.","Net proceeds to be used for capital expenditures and general corporate purposes.","Notes secured by pledge of shares of Trulieve US; rank senior to unsecured indebtedness.","Optional redemption from Dec 2027 at 104% of principal stepping down to 100% by Dec 2029."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2271147618.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124507,"accession_number":"0001754195-25-000071","cik":1754195,"company_name":"Trulieve Cannabis Corp.","ticker":"TCNNF","form_type":"8-K","filed_at":"2025-12-09T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Trulieve raises $100M via 10.5% senior secured notes due 2030","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Gross proceeds of $100M from private placement of 10.5% Senior Secured Notes.","Notes mature December 17, 2030; interest payable semi-annually.","Canaccord Genuity Corp. acts as sole agent and bookrunner.","Proceeds used for capital expenditures and general corporate purposes.","Closing expected on or about December 17, 2025 subject to CSE approval."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2271147618.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124506,"accession_number":"0001754195-25-000064","cik":1754195,"company_name":"Trulieve Cannabis Corp.","ticker":"TCNNF","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Trulieve Q3 revenue $288M, gross margin 59%, adjusted EBITDA $103M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue of $288M, 94% from retail; GAAP gross profit $170M (59% margin).","Net loss attributable to common shareholders $27M; adjusted net loss $12M.","Adjusted EBITDA $103M (36% of revenue), up 7% YoY; operating cash flow $77M, free cash flow $64M.","Cash at quarter end $458M; added CFO Jan Reese and board member Matthew Foulston.","Opened one dispensary in Cincinnati; loyalty program reached 820,000 members."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":888033000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2271147618.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124505,"accession_number":"0001754195-25-000062","cik":1754195,"company_name":"Trulieve Cannabis Corp.","ticker":"TCNNF","form_type":"8-K","filed_at":"2025-11-04T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Trulieve calls all $368M of 8% Notes due 2026; redemption Dec 5, 2025","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Aggregate principal of US$368,000,000 in 8.0% senior secured notes due 2026 to be redeemed.","Redemption date December 5, 2025; price 100% of principal plus accrued interest to redemption date.","Notes currently trade on CSE under TRUL.NT.U; will be delisted upon redemption.","Notice of redemption issued Nov 4, 2025; payment via Odyssey Trust Company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2271147618.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141180,"accession_number":"0001754195-25-000057","cik":1754195,"company_name":"Trulieve Cannabis Corp.","ticker":"TCNNF","form_type":"8-K","filed_at":"2025-08-27T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Trulieve appoints Matthew Foulston to board and Jan Reese as CFO, effective Sept 8, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Matthew Foulston appointed to Trulieve board; former CFO of Covetrus, TreeHouse Foods, and Compass Minerals.","Jan Reese named CFO effective Sept 8, 2025; previously CFO at Vimergy, AVI-SPL, Tech Data Americas, and Motorsport Network.","Reese receives $475k base salary, $380k target annual bonus, and $750k annual equity award eligibility.","Interim CFO Ryan Blust returns to VP Finance role upon Reese's start.","Reese's severance includes 2x salary plus target bonus on non-Cause termination, 2.5x upon Change of Control."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2271147618.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141179,"accession_number":"0001754195-25-000051","cik":1754195,"company_name":"Trulieve Cannabis Corp.","ticker":"TCNNF","form_type":"8-K","filed_at":"2025-08-06T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Trulieve Q2 revenue $302M, adjusted EBITDA $111M (37% of revenue), net loss $14M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $302M comparable to prior year; gross margin 61% vs 60% in Q2 2024.","Net loss attributable to common $14M; adjusted net loss $8M excludes non-recurring charges.","Adjusted EBITDA $111M (37% of revenue), up 3% YoY; cash from ops $86M, free cash flow $75M.","Cash at quarter end $401M; sold 12.5M+ branded products (+9% YoY); opened 3 dispensaries."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":599846000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2271147618.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":158980,"accession_number":"0001754195-25-000042","cik":1754195,"company_name":"Trulieve Cannabis Corp.","ticker":"TCNNF","form_type":"8-K","filed_at":"2025-06-13T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Trulieve shareholders approve 10M share increase to 2021 Omnibus Incentive Plan","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Shareholders added 10M subordinate voting shares to the plan; votes: 46.1M for, 14.4M against, 46.9M broker non-votes.","All seven director nominees elected; Kim Rivers received 47M for (lowest) vs. 13.7M withheld; others passed easily.","Non-binding advisory vote on 2024 executive compensation approved: 52.9M for, 7.3M against.","Ratification of WithumSmith+Brown as auditors for FY 2025 passed: 101.6M for, 5.5M against.","Meeting held June 12, 2025; proposals described in April 29, 2025 proxy statement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":2271147618.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":158979,"accession_number":"0001754195-25-000035","cik":1754195,"company_name":"Trulieve Cannabis Corp.","ticker":"TCNNF","form_type":"8-K","filed_at":"2025-05-07T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Trulieve Q1 revenue $298M, gross margin 62%, adjusted EBITDA $109M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 revenue of $298M, slightly up YoY; 95% from retail sales.","GAAP gross margin improved to 62% from 58%; gross profit of $183M.","Net loss attributable to common shareholders $33M; adjusted net loss $3M.","Adjusted EBITDA of $109M (37% of revenue), up 3% YoY; operating cash flow $51M.","Opened 6 dispensaries in AZ, FL, OH; launched Onward THC beverage."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.16,"consensus_revenue_estimate":null,"consensus_revenue_actual":297760000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":2271147618.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177418,"accession_number":"0001754195-25-000003","cik":1754195,"company_name":"Trulieve Cannabis Corp.","ticker":"TCNNF","form_type":"8-K","filed_at":"2025-03-07T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Trulieve CFO Wes Getman resigns; VP Finance Ryan Blust named interim CFO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Wes Getman resigned as CFO effective March 6, 2025, to pursue other opportunities; no severance paid.","Ryan Blust, VP Finance, appointed interim CFO with no compensation increase; effective immediately.","Blust previously served as interim CFO three times; has over 20 years of accounting and finance experience.","Getman's departure is not due to any disagreement over accounting principles or financial disclosures.","Company has retained an executive search firm to find a permanent CFO."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2271147618.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177417,"accession_number":"0001628280-25-008402","cik":1754195,"company_name":"Trulieve Cannabis Corp.","ticker":"TCNNF","form_type":"8-K","filed_at":"2025-02-27T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Trulieve Q4 revenue $301M (+5% YoY), gross margin 62%; FY2024 record FCF $150M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2024 revenue $301M, up 5% YoY; gross margin 62% vs 54% in Q4 2023.","FY2024 revenue $1.2B (+5% YoY); GAAP gross profit $716M (60% margin).","FY2024 adjusted EBITDA $420M (35% of revenue), up 30% YoY; record ops cash flow $271M, FCF $150M.","Net loss attributable to common $155M; adjusted net loss $19M (excl. non-recurring items & impairments).","Added 33 dispensaries in 2024 to total 225; launched adult-use sales at three Ohio locations."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.79,"consensus_revenue_estimate":null,"consensus_revenue_actual":1186490000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":2271147618.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194155,"accession_number":"0001628280-24-045096","cik":1754195,"company_name":"Trulieve Cannabis Corp.","ticker":"TCNNF","form_type":"8-K","filed_at":"2024-11-05T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Trulieve Q3 revenue $284M, gross margin 61%; $48M campaign spend drives net loss $60M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $284M (+3% YoY); gross margin 61% vs 52% in Q3 2023; adjusted EBITDA $96M (34% revenue), up 24% YoY.","Net loss $60M; adjusted net loss $12M after excluding $48M in Florida adult-use campaign support and other non-recurring items.","Cash flow from operations $30M; free cash flow -$7M impacted by $48M campaign support; cash and short-term investments $319M.","Launched adult-use sales at 3 Ohio locations; opened 15 new dispensaries in FL and PA; 30% of retail locations now outside Florida."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.52,"consensus_revenue_estimate":null,"consensus_revenue_actual":885345000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2271147618.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210478,"accession_number":"0001628280-24-034969","cik":1754195,"company_name":"Trulieve Cannabis Corp.","ticker":"TCNNF","form_type":"8-K","filed_at":"2024-08-06T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Trulieve Q2 revenue $303M up 8% YoY; gross margin 60%; launches Ohio adult-use sales","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue of $303M (+2% seq, +8% YoY); 95% from retail; gross profit $182M (60% margin).","Net loss $12M (improved 48% seq); adjusted net income $0.2M; adjusted EBITDA $107M (35% of rev).","Cash from ops $71M; free cash flow $45M; cash $356M; received $2M tax refunds from 280E challenge.","Opened 3 new FL dispensaries; acquired 2 in OH; launched adult-use sales in OH on Aug 6 at 3 locations.","200th retail location milestone; 32% of retail locations outside Florida."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.21,"consensus_revenue_estimate":null,"consensus_revenue_actual":601061000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2271147618.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228804,"accession_number":"0001628280-24-028047","cik":1754195,"company_name":"Trulieve Cannabis Corp.","ticker":"TCNNF","form_type":"8-K","filed_at":"2024-06-13T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Trulieve shareholders approve 2nd amended 2021 Omnibus Incentive Plan, adding 5.5M shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders approved increasing the share pool by 5,500,000 subordinate voting shares for equity awards.","All five proposals passed at June 12 annual meeting; the amended plan had 52.2M for, 5.9M against, 2.6M abstain.","Board size set at seven directors; all seven director nominees elected with over 52.7M votes for each.","Non-binding advisory vote on 2023 named-executive compensation passed with 50.9M for, 7.9M against.","WithumSmith+Brown, PC ratified as auditor for 2024 with 109.5M votes for."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":2271147618.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228803,"accession_number":"0001628280-24-021918","cik":1754195,"company_name":"Trulieve Cannabis Corp.","ticker":"TCNNF","form_type":"8-K","filed_at":"2024-05-09T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Trulieve Q1 2024 revenue $298M, up 4% sequentially; adjusted EBITDA $106M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue of $298M (+4% sequentially & YoY); 58% GAAP gross margin on $174M gross profit.","Net loss $23M improved 31% sequentially; adjusted net loss $10M; adjusted EBITDA $106M (36% of revenue).","Operating cash flow $139M, free cash flow $124M; cash $327M including $50M tax refunds from 280E challenge.","Opened 3 Florida dispensaries (Cocoa Beach, Palm Bay, Pinellas Park); 31% of retail locations outside Florida.","Progress on Smart and Safe Florida adult-use initiative and federal cannabis rescheduling to Schedule III."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.16,"consensus_revenue_estimate":null,"consensus_revenue_actual":297619000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2271147618.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}